COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

COPD graphic | Image Credit: Maks_Lab - stock.adobe.com
Systemic Immune Response Index Identified as Independent Risk Factor for COPD

March 23rd 2025

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary disease (COPD).

sleeping baby in father's arms | Image Credit: BazziBa - stock.adobe.com
Low Birth Weight Linked to Increased COPD Risk

December 30th 2024

TOP 5 COPD articles of 2024 | Image Credit: Venngage
Top 5 Most-Read COPD Content of 2024

December 26th 2024

CHEST 2024 highlights | Image Credit: Venngage
ICYMI: Highlights From CHEST 2024

December 19th 2024

ATS 2024 highlights
ICYMI: Highlights From ATS 2024

December 16th 2024

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Continuing Medical Education
View All
June 16th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Monitoring Response to Therapy in COPD
January 16th 2020

Monitoring Response to Therapy in COPD

Establishing Goals of Therapy in COPD
January 16th 2020

Establishing Goals of Therapy in COPD

Pulmonary Function Testing in COPD
January 16th 2020

Pulmonary Function Testing in COPD

Accurately Diagnosing COPD
January 16th 2020

Accurately Diagnosing COPD

Progressive Nature of COPD
January 16th 2020

Progressive Nature of COPD

Characteristics That Help Diagnose COPD
January 16th 2020

Characteristics That Help Diagnose COPD

COPD Defined
January 16th 2020

COPD Defined

COPD Disease Burden
January 16th 2020

COPD Disease Burden

Tracheobronchial Colonization Found to Significantly Increase Mortality Risk Among Patients With COPD
January 16th 2020

Tracheobronchial Colonization Found to Significantly Increase Mortality Risk Among Patients With COPD

Matthew Gavidia
Tracheobronchial colonization by pseudomonas aeruginosa was shown to increase the mortality risk of outpatients with chronic obstructive plumonary disease (COPD) by 47%, according to study results.
Researchers Suggest Reduction, Optimization of Antibiotic Prescriptions to Limit Drug Resistance Risk for Patients With Mild to Moderate COPD
January 11th 2020

Researchers Suggest Reduction, Optimization of Antibiotic Prescriptions to Limit Drug Resistance Risk for Patients With Mild to Moderate COPD

Sara Karlovitch
For those with mild to moderate chronic obstructive pulmonary disease (COPD), researchers suggest that antibiotic stewardship focus on reducing and optimizing antibiotic use in patients with severe COPD who have a significant risk of drug resistance, according to study findings.
Cancer Treatments Exhibit Potential Therapeutic Efficacy Toward COPD, Study Shows
January 8th 2020

Cancer Treatments Exhibit Potential Therapeutic Efficacy Toward COPD, Study Shows

Matthew Gavidia
Specific cancer drugs were shown to inhibit cell signaling processes that contribute to neutrophils, immune cells that cause inflammation to the lungs and serve as the main driver of lung damage in patients with chronic obstructive pulmonary disease (COPD), according to study findings.
Inspiratory Muscle Strength Not Linked to Symptoms in Patients With COPD, Study Finds
December 31st 2019

Inspiratory Muscle Strength Not Linked to Symptoms in Patients With COPD, Study Finds

Gianna Melillo
Maximal inspiratory pressure (MIP) is associated with leg muscle strength in patients with chronic obstructive pulmonary disease (COPD), but not with walking distance or symptoms exhibited by the same patients, according to a recent study.
Site Logo
December 26th 2019

Explore What's Possible: Achieving Optimal COPD Management

Thomas C. Corbridge, MD, FCCP
Thomas C. Corbridge, MD, FCCP, is a GSK medical expert and an emeritus physician and adjunct professor of medicine at Northwestern University, Feinberg School of Medicine in Chicago, Illinois. Dr. Corbridge received his medical degree from the University of Chicago Pritzker School of Medicine and has been in practice for over 30 years. Dr. Corbridge specializes in pulmonary and critical care medicine and is experienced in asthma, chronic obstructive pulmonary disease and general pulmonology.
Swedish Study Finds "Closing Gap" of COPD Prevalence in Both Genders
December 21st 2019

Swedish Study Finds "Closing Gap" of COPD Prevalence in Both Genders

Gianna Melillo
A recently published study amassed real-world evidence from patients with chronic obstructive pulmonary disease (COPD), concluding that “there has been a closing of the gap in COPD prevalence among both genders.”
Expiratory Flow Limitation in ICU Patients With COPD Linked to Adverse Outcomes
December 14th 2019

Expiratory Flow Limitation in ICU Patients With COPD Linked to Adverse Outcomes

Alison Rodriguez
The study aimed to assess the prevalence of expiratory flow limitation in patients who require mechanical ventilation for acute respiratory failure.
Provider Intervention Leads to Increased Flu Vaccination Rates Among Patients With COPD
December 14th 2019

Provider Intervention Leads to Increased Flu Vaccination Rates Among Patients With COPD

Gianna Melillo
Physician and nurse interventions are the most effective means of promoting influenza vaccinations among patients with chronic obstructive pulmonary disease (COPD), according to the results of a pilot project.
Study Investigates the Role of Peak Oxygen Pulse in Patients With COPD
December 7th 2019

Study Investigates the Role of Peak Oxygen Pulse in Patients With COPD

Alison Rodriguez
A recent study explored the role of peak oxygen pulse (O2P) in patients with chronic obstructive pulmonary disease (COPD).
Novel Airway-Clearing Technology Shows Potential in Adolescent Patients With COPD, Other Respiratory Diseases
December 6th 2019

Novel Airway-Clearing Technology Shows Potential in Adolescent Patients With COPD, Other Respiratory Diseases

Matthew Gavidia
A novel device that unblocks and removes secretions from the respiratory tracts of children was developed by researchers in Israel and the United States, and may prove beneficial among patients with respiratory diseases such as chronic obstructive pulmonary disease (COPD).
Positive Expiratory Pressure Device Shows Some Results for Patients With COPD
November 30th 2019

Positive Expiratory Pressure Device Shows Some Results for Patients With COPD

Alison Rodriguez
Adjunctive therapy with a positive expiratory pressure (PEP) device may possibly decrease the length of hospital stays for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), researchers suggested in a set of 2 small studies published in the International Journal of Chronic Obstructive Pulmonary Disease.
COPD Mortality Rate Drops in Some Countries, While Total Mortality Rises, Study Finds
November 27th 2019

COPD Mortality Rate Drops in Some Countries, While Total Mortality Rises, Study Finds

Matthew Gavidia
An international study examining trends in COPD mortality over more than 2 decades showed that COPD mortality rates declined in most countries, but remained stable among US women and increased in several European countries, with total mortality additionally increasing or remaining stable in most countries.
TMF Health Quality Institute Highlights Benefit of COPD Rescue Pack in Suppressing Exacerbations
November 21st 2019

TMF Health Quality Institute Highlights Benefit of COPD Rescue Pack in Suppressing Exacerbations

Matthew Gavidia
As part of its Quality Improvement Snapshots series, TMF Health Quality Institute issued 4 healthcare quality improvement efforts, highlighting the use of a rescue pack for patients with chronic obstructive pulmonary disease (COPD) as an impactful strategy in managing COPD-related exacerbations.
Site Logo
November 18th 2019

Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT

Richard H. Stanford, PharmD, MS Anna D. Coutinho, PhD Michael Eaddy, PharmD, PhD Binglin Yue, MS Michael Bogart, PharmD
This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
Study Results Call for Attention to Sex Differences in COPD
November 16th 2019

Study Results Call for Attention to Sex Differences in COPD

Alison Rodriguez
Clinical characteristics of women with chronic obstructive pulmonary disease (COPD) are important for primary care clinicians to consider in order to improve COPD awareness since women often go underdiagnosed, according to results from a recent study.
Researchers Propose New Diagnostic Criteria for COPD
November 12th 2019

Researchers Propose New Diagnostic Criteria for COPD

Matthew Gavidia
Researchers proposed new diagnostic criteria for chronic obstructive pulmonary disease (COPD) that seek to identify more patients in early stages of the disease, promote better care for patients, and stimulate research to slow and prevent COPD, in a paper published today in the journal Chronic Obstructive Pulmonary Diseases.
Pulmonary Rehabilitation for COPD May Be Effective Regardless of Socioeconomic Status, Study Finds
November 9th 2019

Pulmonary Rehabilitation for COPD May Be Effective Regardless of Socioeconomic Status, Study Finds

Alison Rodriguez
Socially deprived patients were younger, more frequently women, active smokers, living alone, and belonged to lower socioprofessional categories when compared with the non-socially deprived group, but they still benefitted from home-based pulmonary rehabilitation.
Inhaled Corticosteroid Use for COPD Treatment Linked to Increased Risk of Pneumonia
November 8th 2019

Inhaled Corticosteroid Use for COPD Treatment Linked to Increased Risk of Pneumonia

Matthew Gavidia
The use of fluticasone-containing inhaled corticosteroids (ICS) was linked to increased risk of pneumonia in patients with COPD, according to study findings.
Review Suggests Approaches for Identifying COPD Should Be Combined
November 3rd 2019

Review Suggests Approaches for Identifying COPD Should Be Combined

Alison Rodriguez
A review evaluating the methodological approaches of identifying chronic obstructive pulmonary disease (COPD) found that when more criteria is combined, the more accurate the detection of COPD in terms of sensitivity and specificity.
Exposure to Disinfectants, Cleaning Products Linked to COPD Risk Among Female Nurses
October 29th 2019

Exposure to Disinfectants, Cleaning Products Linked to COPD Risk Among Female Nurses

Matthew Gavidia
Regular use of chemical disinfectants among female nurses was found to be a potential risk factor for the development of chronic obstructive pulmonary disease (COPD), according to study findings.
Study Finds Combination Therapy Reduces Number of COPD Exacerbations
October 26th 2019

Study Finds Combination Therapy Reduces Number of COPD Exacerbations

Alison Rodriguez
Patients with severe chronic obstructive pulmonary disorder (COPD) and chronic bronchial infection due to Pseudomonas aeruginosa may benefit from combination therapy with nebulized colistin and continuous cyclic azithromycin for reducing the number of COPD exacerbations.
Long-Term Lung Damage Found In Ex-Smokers, Light Smokers
October 21st 2019

Long-Term Lung Damage Found In Ex-Smokers, Light Smokers

Matthew Gavidia
People who are former smokers or who smoke fewer than 5 cigarettes a day were shown to have long-term damage to their lungs, which can increase the risk of developing chronic obstructive pulmonary disease, according to a study.
<1
...
101112131415161718
...
26>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo